BlackRock »

Cara Therapeutics shares owned by BlackRock

Quarter-by-quarter ownership of Cara Therapeutics (CARA) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Cara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cara Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cara Therapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $229k 743k 0.31

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Cara Therapeutics

Vanguard Group
Chescapmanager
Farallon Capital Management
Disciplined Growth Investors
Renaissance Technologies
Two Sigma Advisers
BlackRock
BlackRock
Bnp Paribas Arbitrage, Snc
Geode Capital Management
Stifel Financial
Goldman Sachs Group
Bank of America Corporation
Two Sigma Investments
State Street Corporation

View all funds holding Cara Therapeutics